Regal Assets Analytics

SanaCurrents

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By |2019-03-25T11:45:49-04:00March 25th, 2019|Categories: Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , |

One of the strongest performing biopharmaceutical stocks this year is [...]

ADMA New Catalysts For 2019 – Two PDUFA decisions on immunodeficiency therapies

By |2019-01-22T10:10:21-04:00January 22nd, 2019|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY SanaCurrents assigns a pivotal sentiment the FDA will approve [...]

Verona Pharma (VRNA) January 2019 Catalyst: Topline data for RPL554

By |2019-01-22T10:17:48-04:00January 8th, 2019|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY Sana Currents assigns a pivotal sentiment that Verona Pharma [...]

Cara Therapeutics (CARA) Q1 2019 Catalyst: Phase III efficacy trial, KALM-2

By |2019-01-22T10:10:46-04:00January 2nd, 2019|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , |

SUMMARY Sana Currents assigns a pivotal sentiment that Cara Therapeutics [...]

Karyopharm’s Cancer Drug Achieves Impressive Results

By |2018-12-04T16:07:17-04:00December 2nd, 2018|Categories: Health Care Equipment & Services, Healthcare, Insights, Insights-Home, Pharmaceutical & Biotechnology|Tags: , , , , , |

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 [...]

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X

By |2019-01-22T10:03:50-04:00November 21st, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , , , , |

3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is [...]

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) – December Catalyst, Lymphoma Phase IIb Trial

By |2019-01-22T10:03:59-04:00November 21st, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , , , , |

December catalyst, lymphoma phase IIb trial SanaCurrents assigns a pivotal [...]